ALKERMES | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
ALKERMES USD 1.46B 172.88M 2024-12
Amgen USD 5.88B 1.65B 2024-12
Biogen USD 16.72B 357.1M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
Intra Cellular Therapies USD 1.15B 3.63M 2024-12
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
J&J USD 71.49B 1.33B 2024-12
Malin Corporation EUR 118.2M 8.7M 2024-06
Merck USD 46.31B 1.81B 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Otsuka Holdings JPY 2.73T 225.38B 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



ALKERMES Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.